Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
British Journal of Cancer|July 1, 1980
Immune-complex disease in mice and humans given C. parvumH D Mitcheson, J Uff, B A Pussell, et al.
British Journal of Urology|July 1, 1988
Development of bladder tumour containing HPV type 11 DNA after renal transplantationG Querci della Rovere, R T Oliver, D J McCance, et al.
British Medical Journal|June 25, 1977
Peptic ulceration, gastric secretion, and renal transplantationG D Chisholm, A D Mee, G Williams, et al.
The Journal of Pathology|February 1, 1981
Proliferative glomerulonephritis in mice given intravenous Corynebacterium parvumJ S Uff, H D Mitcheson, B A Pussell, et al.
Critical Reviews in Oncology/Hematology|January 26, 2021
Chimeric antigen receptor T cell therapy in oncology - Pipeline at a glance: Analysis of the ClinicalTrials.gov databaseE Moreno-Cortes, J V Forero-Forero, P A Lengerke-Diaz, et al.
Leukemia|August 30, 2008
Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemiaJ E Castro, J D Sandoval-Sus, J Bole, et al.
Evaluation & the Health Professions|November 7, 2000
Chronic fatigue syndrome: sociodemographic subtypes in a community-based sampleL A Jason, R R Taylor, C L Kennedy, et al.
Molecular Psychiatry|February 24, 2010
Macrophage migration inhibitory factor is critically involved in basal and fluoxetine-stimulated adult hippocampal cell proliferation and in anxiety, depression, and memory-related behaviorsL Conboy, E Varea, J E Castro, et al.
Cytometry|November 20, 1998
Detection of rare apoptotic T cells in vivoJ A Listman, Y Wang, J E Castro, et al.
Blood Cancer Journal|November 15, 2014
Ofatumumab and high-dose methylprednisolone for the treatment of patients with relapsed or refractory chronic lymphocytic leukemiaJ E Castro, M Y Choi, T Carvajal, et al.
Pageof 8